Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Asian Journal of Transfusion Science|October 6, 2022
Prevalence and specificity of red blood cell alloantibodies and autoantibodies in transfused Iranian β-thalassemia patients: A systematic review and meta-analysisHosein Rostamian, Ehsan Javandoost, Mozhdeh Mohammadian, et al.
Pharmacy (Basel, Switzerland)|June 25, 2025
Application of Fuzzy AHP for Medication Decision Making in Iron-Chelating Medications for ThalassemiaSaeed Barzegari, Hosein Rostamian, Ehsan Firoozi-Majd, et al.
Current Medicinal Chemistry|September 24, 2019
Role of microRNAs in Chronic Lymphocytic Leukemia PathogenesisEhsan Javandoost, Ehsan Firoozi-Majd, Hosein Rostamian, et al.
Cancer Immunology Research|August 4, 2021
Mitochondria as Playmakers of CAR T-cell Fate and LongevityHosein Rostamian, Mohammad Khakpoor-Koosheh, Keyvan Fallah-Mehrjardi, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Rapid CRISPR-Cas9 Genome Editing in S. cerevisiaeHosein Rostamian, Ethan W Madden, Frank M Kaplan, et al.
Cancer Letters|December 8, 2020
A metabolic switch to memory CAR T cells: Implications for cancer treatmentHosein Rostamian, Keyvan Fallah-Mehrjardi, Mohammad Khakpoor-Koosheh, et al.
Molecular Immunology|August 27, 2021
Targeted knockdown of Tim3 by short hairpin RNAs improves the function of anti-mesothelin CAR T cellsLeila Jafarzadeh, Elham Masoumi, Hamid Reza Mirzaei, et al.
Immunology Letters|April 15, 2020
Pharmacological targeting of immune checkpoint A2aR improves function of anti-CD19 CAR T cells in vitroKeyvan Fallah-Mehrjardi, Hamid Reza Mirzaei, Elham Masoumi, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 11, 2020
Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cellsElham Masoumi, Leila Jafarzadeh, Hamid Reza Mirzaei, et al.
Pageof 2